PBT-1033
CAS No. 747408-78-2
PBT-1033 ( PB 1033 | PBT-2 | PBT1033 | PBT2 | PBT 1033 | PBT 2 )
产品货号. M24759 CAS No. 747408-78-2
PBT-1033(PBT-2) 是一种潜在的神经保护剂,用于治疗阿尔茨海默病和亨廷顿舞蹈病。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥551 | 有现货 |
|
| 5MG | ¥810 | 有现货 |
|
| 10MG | ¥1199 | 有现货 |
|
| 25MG | ¥2130 | 有现货 |
|
| 50MG | ¥3167 | 有现货 |
|
| 100MG | ¥4739 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PBT-1033
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PBT-1033(PBT-2) 是一种潜在的神经保护剂,用于治疗阿尔茨海默病和亨廷顿舞蹈病。
-
产品描述PBT-1033(PBT-2) is a potential neuroprotective agent for the treatment of Alzheimer's disease and Huntington's disease.
-
体外实验PB 1033 displays antibacterial activity against S. uberis, with a MIC value of 14.5?μM.PBT2 (1, 3 and 7.5 μM, 6 h) protects neurons against glutamate-induced excitotoxicity.PBT2 (10 μM, 1 or 6 h) reduces NMDAR-mediated Ca2+ flux in mouse cortical neurons.PBT2 (0-10 μM, 1 h) increases GSK3α/β phosphorylation in SH-SY5Y cells.PBT2 (20 μM, 1 h) prevents the formation of Zn-induced protease resistant Aβ aggregates. Western Blot Analysis Cell Line:SH-SY5Y cells Concentration:0-10 μM Incubation Time:1 h Result:Increased in cellular levels of GSK3α/β phosphorylated at the inhibitory serine 21/9 residue (ser21/9 on GSK3α/β).
-
体内实验PBT 1033 (30 mg/kg/d, p.o., 11 days) restores biochemical substrates of learning/memory in a mouse model of alzheimer's disease. Animal Model:Female Tg2576 miceDosage:30 mg/kg/d Administration:Oral administration, 11 days Result:Increased hippocampal apical spine density, basal spine density.
-
同义词PB 1033 | PBT-2 | PBT1033 | PBT2 | PBT 1033 | PBT 2
-
通路Others
-
靶点Other Targets
-
受体others
-
研究领域——
-
适应症——
化学信息
-
CAS Number747408-78-2
-
分子量271.14
-
分子式C12H12Cl2N2O
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (368.81 mM)
-
SMILESCN(C)Cc1ccc(c(Cl)cc(Cl)c2O)c2n1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Huntington Study Group Reach2HD Investigators.. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015 Jan;14(1):39-47. doi: 10.1016/S1474-4422(14)70262-5. PubMed PMID: 25467848.
产品手册
关联产品
-
Parathyroid Hormone ...
Parathyroid Hormone (1-34)-Lys(Biotin), human
-
6-Methoxy-bispyranox...
6-Methoxy-bispyranoxanthone
-
(D-Pro2,D-Phe7,D-Trp...
(D-Pro2,D-Phe7,D-Trp9)-Substance P
021-51111890
购物车()
sales@molnova.cn

